153 related articles for article (PubMed ID: 16304360)
1. An evidence-based approach to the treatment of adults with sickle cell disease.
Lottenberg R; Hassell KL
Hematology Am Soc Hematol Educ Program; 2005; ():58-65. PubMed ID: 16304360
[TBL] [Abstract][Full Text] [Related]
2. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
3. Current issues in blood transfusion for sickle cell disease.
Wahl S; Quirolo KC
Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238
[TBL] [Abstract][Full Text] [Related]
4. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines.
Josephson CD; Su LL; Hillyer KL; Hillyer CD
Transfus Med Rev; 2007 Apr; 21(2):118-33. PubMed ID: 17397762
[TBL] [Abstract][Full Text] [Related]
5. [Blood transfusion assessment to 112 homozygous sickle-cell disease patients in university hospital of Brazzaville].
Dokekias AE; Ossini LN; Tsiba FO; Malanda F; Koko I; De Montalembert M
Transfus Clin Biol; 2009; 16(5-6):464-70. PubMed ID: 19369104
[TBL] [Abstract][Full Text] [Related]
6. A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease.
Pack-Mabien A; Haynes J
J Am Acad Nurse Pract; 2009 May; 21(5):250-7. PubMed ID: 19432908
[TBL] [Abstract][Full Text] [Related]
7. Emergency Medicine Management of Sickle Cell Disease Complications: An Evidence-Based Update.
Simon E; Long B; Koyfman A
J Emerg Med; 2016 Oct; 51(4):370-381. PubMed ID: 27553919
[TBL] [Abstract][Full Text] [Related]
8. Sickle cell disease: when and how to transfuse.
Howard J
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):625-631. PubMed ID: 27913538
[TBL] [Abstract][Full Text] [Related]
9. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
10. Transfusion management in sickle cell disease.
Wanko SO; Telen MJ
Hematol Oncol Clin North Am; 2005 Oct; 19(5):803-26, v-vi. PubMed ID: 16214645
[TBL] [Abstract][Full Text] [Related]
11. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
12. Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery.
Al-Samak ZM; Al-Falaki MM; Pasha AA
Middle East J Anaesthesiol; 2008 Jun; 19(5):983-95. PubMed ID: 18637600
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, treatment, and outcomes of renal conditions in pediatric sickle cell disease.
Stallworth JR; Tripathi A; Jerrell JM
South Med J; 2011 Nov; 104(11):752-6. PubMed ID: 22024785
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma sVCAM-1 levels in children with sickle cell disease: impact of chronic transfusion therapy.
Sakhalkar VS; Rao SP; Weedon J; Miller ST
Am J Hematol; 2004 May; 76(1):57-60. PubMed ID: 15114598
[TBL] [Abstract][Full Text] [Related]
15. Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative.
DeBaun MR; King AA
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):632-639. PubMed ID: 27913539
[TBL] [Abstract][Full Text] [Related]
16. Preoperative transfusion in patients with sickle cell disease to prevent perioperative complications: a systematic review and meta-analysis.
Alotaibi GS; Alsaleh K; Bolster L; McMurtry MS; Wu C
Hematology; 2014 Dec; 19(8):463-71. PubMed ID: 24611757
[TBL] [Abstract][Full Text] [Related]
17. Preoperative transfusion versus no transfusion policy in sickle cell disease patients: a randomized trial.
Elshinawy M; Al Marhoobi N; Al Abri R; Nazir HF; Khater D; Maktoom M; Al-Rawas A; Mevada ST; Elghamry I; Wali Y
Transfusion; 2020 Feb; 60 Suppl 1():S22-S27. PubMed ID: 32134128
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of a preoperative risk-based transfusion assignment protocol in sickle cell disease patients: a single-center retrospective study from Saudi Arabia.
Albolowi N; Mustafa O; Almohammadi M; Al-Hindi MY; Jastaniah W
Pediatr Hematol Oncol; 2020 Oct; 37(7):599-609. PubMed ID: 32459595
[TBL] [Abstract][Full Text] [Related]
19. A comparison of two transfusion regimens in the perioperative management of children with sickle cell disease undergoing adenotonsillectomy.
Wali YA; al Okbi H; al Abri R
Pediatr Hematol Oncol; 2003; 20(1):7-13. PubMed ID: 12687748
[TBL] [Abstract][Full Text] [Related]
20. Managing sickle cell disease and related complications in pregnancy: results of an international Delphi panel.
Sharma D; Kozanoğlu I; Ataga KI; Benachi A; Büyükkurt S; Lanzkron S; Ozdogu H; Pancham S; Pecker LH; Robinson SE; Yilmaz Baran S; Howard J
Blood Adv; 2024 Feb; 8(4):1018-1029. PubMed ID: 38206762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
